Effect Of Probiotics Supplementation on Outcome Of Malnourished Children
1 other identifier
observational
102
0 countries
N/A
Brief Summary
The Outcome Of malnourished children who receive probiotics (Lactobacillus and Bifidobacterium
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2025
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2024
CompletedFirst Posted
Study publicly available on registry
September 23, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedSeptember 23, 2024
September 1, 2024
11 months
September 5, 2024
September 18, 2024
Conditions
Outcome Measures
Primary Outcomes (7)
Aim of the study
The Outcome Of malnourished children who receive probiotics (Lactobacillus and Bifidobacterium)
Baseline
perinatal history
1. full term or preterm 2. type of delivery 3. NICU admission
Baseline
Present history
1. disease type 2. onset 3. course 4. duration 5. stool \&urine characters.
Baseline
Feeding history
1. breast feeding 2. suckling power 3. formula feeding
Baseline
Maternal history
1. The history of pregnancy and delivery 2. Any maternal complications or illness during the pregnancy 3. Usage of any drugs
Baseline
Investigations
1. complete blood count 2. liver function test 3. kidney function test 4. Random blood glucose
Baseline
Sample size
102 patients
Baseline
Eligibility Criteria
The Outcome Of malnourished children who receive probiotics (Lactobacillus and Bifidobacterium)
You may qualify if:
- Age group of children from 6 month up to 5 years
You may not qualify if:
- age below 6 month and above 5 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016 Aug 19;14(8):e1002533. doi: 10.1371/journal.pbio.1002533. eCollection 2016 Aug.
PMID: 27541692BACKGROUNDBakker GJ, Zhao J, Herrema H, Nieuwdorp M. Gut Microbiota and Energy Expenditure in Health and Obesity. J Clin Gastroenterol. 2015 Nov-Dec;49 Suppl 1:S13-9. doi: 10.1097/MCG.0000000000000363.
PMID: 26447957RESULTvan den Elsen LW, Poyntz HC, Weyrich LS, Young W, Forbes-Blom EE. Embracing the gut microbiota: the new frontier for inflammatory and infectious diseases. Clin Transl Immunology. 2017 Jan 20;6(1):e125. doi: 10.1038/cti.2016.91. eCollection 2017 Jan.
PMID: 28197336RESULT
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- 71515,Assuit
Study Record Dates
First Submitted
September 5, 2024
First Posted
September 23, 2024
Study Start
January 1, 2025
Primary Completion
November 30, 2025
Study Completion
January 1, 2026
Last Updated
September 23, 2024
Record last verified: 2024-09